These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 11108267
1. Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone. Ballock RT, Zhou X, Mink LM, Chen DH, Mita BC, Stewart MC. Endocrinology; 2000 Dec; 141(12):4552-7. PubMed ID: 11108267 [Abstract] [Full Text] [Related]
2. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Robker RL, Richards JS. Mol Endocrinol; 1998 Jul; 12(7):924-40. PubMed ID: 9658398 [Abstract] [Full Text] [Related]
3. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related]
4. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Phelps DE, Xiong Y. Cell Growth Differ; 1998 Aug 15; 9(8):595-610. PubMed ID: 9716177 [Abstract] [Full Text] [Related]
5. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Schreiber M, Muller WJ, Singh G, Graham FL. Oncogene; 1999 Mar 04; 18(9):1663-76. PubMed ID: 10208428 [Abstract] [Full Text] [Related]
6. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation. Stewart MC, Kadlcek RM, Robbins PD, MacLeod JN, Ballock RT. J Bone Miner Res; 2004 Jan 04; 19(1):123-32. PubMed ID: 14753744 [Abstract] [Full Text] [Related]
7. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Gray-Bablin J, Rao S, Keyomarsi K. Cancer Res; 1997 Feb 15; 57(4):604-9. PubMed ID: 9044834 [Abstract] [Full Text] [Related]
8. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Matsuo T, Thiele CJ. Oncogene; 1998 Jun 25; 16(25):3337-43. PubMed ID: 9681834 [Abstract] [Full Text] [Related]
9. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M. Hepatology; 2001 May 25; 33(5):1087-97. PubMed ID: 11343236 [Abstract] [Full Text] [Related]
10. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB. Mol Endocrinol; 1997 Oct 25; 11(11):1593-607. PubMed ID: 9328342 [Abstract] [Full Text] [Related]
11. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Chellappan SP, Giordano A, Fisher PB. Curr Top Microbiol Immunol; 1998 Oct 25; 227():57-103. PubMed ID: 9479826 [No Abstract] [Full Text] [Related]
13. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Gill RM, Slack R, Kiess M, Hamel PA. Exp Cell Res; 1998 Oct 10; 244(1):157-70. PubMed ID: 9770359 [Abstract] [Full Text] [Related]
14. Thyroid hormone, retinoic acid, and testosterone suppress proliferation and induce markers of differentiation in cultured rat sertoli cells. Buzzard JJ, Wreford NG, Morrison JR. Endocrinology; 2003 Sep 10; 144(9):3722-31. PubMed ID: 12933640 [Abstract] [Full Text] [Related]
15. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation. Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M. Oncogene; 1998 Oct 29; 17(17):2259-69. PubMed ID: 9811456 [Abstract] [Full Text] [Related]
16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 29; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
17. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J. Oncogene; 1996 Jan 18; 12(2):309-22. PubMed ID: 8570208 [Abstract] [Full Text] [Related]
18. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Hum Pathol; 2000 Jun 18; 31(6):751-60. PubMed ID: 10872671 [Abstract] [Full Text] [Related]
19. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Coppée F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE. Oncogene; 1998 Aug 06; 17(5):631-41. PubMed ID: 9704929 [Abstract] [Full Text] [Related]
20. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y, Kyprianou N. Cell Growth Differ; 1998 Feb 06; 9(2):185-93. PubMed ID: 9486855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]